These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34122555)

  • 1. Interleukin-20 Acts as a Promotor of Osteoclastogenesis and Orthodontic Tooth Movement.
    Liu Y; Ai Y; Sun X; Meng B; Chen X; Wu D; Gan L; Yang B; Fu C; Wu Y; Cao Y
    Stem Cells Int; 2021; 2021():5539962. PubMed ID: 34122555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-20 differentially regulates bone mesenchymal stem cell activities in RANKL-induced osteoclastogenesis through the OPG/RANKL/RANK axis and the NF-κB, MAPK and AKT signalling pathways.
    Meng B; Wu D; Cheng Y; Huang P; Liu Y; Gan L; Liu C; Cao Y
    Scand J Immunol; 2020 May; 91(5):e12874. PubMed ID: 32090353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual Role of Interleukin-20 in Different Stages of Osteoclast Differentiation and Its Osteoimmune Regulation during Alveolar Bone Remodeling.
    Meng B; Yang B; Qu Y; Liu Y; Wu D; Fu C; He Y; Chen X; Liu C; Kou X; Cao Y
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of requirement of receptor activator of nuclear factor κB signaling for interleukin 1-mediated osteoclastogenesis.
    Jules J; Zhang P; Ashley JW; Wei S; Shi Z; Liu J; Michalek SM; Feng X
    J Biol Chem; 2012 May; 287(19):15728-38. PubMed ID: 22416138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RANKL release from self-assembling nanofiber hydrogels for inducing osteoclastogenesis in vitro.
    Xing JZ; Lu L; Unsworth LD; Major PW; Doschak MR; Kaipatur NR
    Acta Biomater; 2017 Feb; 49():306-315. PubMed ID: 27940164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Force-induced Adrb2 in periodontal ligament cells promotes tooth movement.
    Cao H; Kou X; Yang R; Liu D; Wang X; Song Y; Feng L; He D; Gan Y; Zhou Y
    J Dent Res; 2014 Nov; 93(11):1163-9. PubMed ID: 25252876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-6 Enhances Osteocyte-Mediated Osteoclastogenesis by Promoting JAK2 and RANKL Activity In Vitro.
    Wu Q; Zhou X; Huang D; Ji Y; Kang F
    Cell Physiol Biochem; 2017; 41(4):1360-1369. PubMed ID: 28278513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
    Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
    Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling.
    Kalliolias GD; Zhao B; Triantafyllopoulou A; Park-Min KH; Ivashkiv LB
    Arthritis Rheum; 2010 Feb; 62(2):402-13. PubMed ID: 20112358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
    Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K
    J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTH/PTHrP in controlled release hydrogel enhances orthodontic tooth movement by regulating periodontal bone remodaling.
    Lu W; Li X; Yang Y; Yi J; Xie L; Zhao Z; Li Y
    J Periodontal Res; 2021 Oct; 56(5):885-896. PubMed ID: 33856055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vibration enhances osteoclastogenesis by inducing RANKL expression via NF-κB signaling in osteocytes.
    Sakamoto M; Fukunaga T; Sasaki K; Seiryu M; Yoshizawa M; Takeshita N; Takano-Yamamoto T
    Bone; 2019 Jun; 123():56-66. PubMed ID: 30902792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells.
    Kim JM; Lee JH; Lee GS; Noh EM; Song HK; Gu DR; Kim SC; Lee SH; Kwon KB; Lee YR
    BMC Complement Altern Med; 2017 Mar; 17(1):164. PubMed ID: 28335757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages.
    Jin G; Wang FF; Li T; Jia DD; Shen Y; Xu HC
    Med Sci Monit; 2018 Apr; 24():2569-2577. PubMed ID: 29698379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoclastic effects of mBMMSCs under compressive pressure during orthodontic tooth movement.
    Wang J; Jiao D; Huang X; Bai Y
    Stem Cell Res Ther; 2021 Feb; 12(1):148. PubMed ID: 33632323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 29 inhibits RANKL-induced osteoclastogenesis via activation of JNK and STAT, and inhibition of NF-κB and NFATc1.
    Peng Q; Luo A; Zhou Z; Xuan W; Qiu M; Wu Q; Xu L; Kong X; Zhang M; Tan W; Xue M; Wang F
    Cytokine; 2019 Jan; 113():144-154. PubMed ID: 30001863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylsulfonylmethane Inhibits RANKL-Induced Osteoclastogenesis in BMMs by Suppressing NF-κB and STAT3 Activities.
    Joung YH; Darvin P; Kang DY; Sp N; Byun HJ; Lee CH; Lee HK; Yang YM
    PLoS One; 2016; 11(7):e0159891. PubMed ID: 27447722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sclareol inhibits RANKL-induced osteoclastogenesis and promotes osteoblastogenesis through promoting CCN1 expression via repressing the MAPK pathway.
    Li X; Wang Y; Li L; Zhou S; Zhao F
    Cell Biol Toxicol; 2021 Dec; 37(6):849-871. PubMed ID: 33423118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosavin suppresses osteoclastogenesis
    Zhang W; Zhang W; Huo L; Chai Y; Liu Z; Ren Z; Yu C
    Ann Transl Med; 2021 Mar; 9(5):383. PubMed ID: 33842604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.